Abstract Compounds useful as complementary DNA (cDNA) include deoxyribonucleotides and at least one ribonucleotide. They may be depicted by the general formula: <IMAGE> wherein (dN)a and (dN)c represent series of deoxyribonucleotides and (rN)b represents a series of ribonucleotides; wherein a, b, and c are the number of nucleotides in the series, with the proviso that b is >/=1, a is >/=35, and c is >/=10; wherein the series of deoxyribonucleotides (dN)a includes a series of deoxyribonucleotides which is substantially complementary to the series of deoxyribonucleotides (dN)c and the dashed line represents noncovalent bonding between the complementary deoxyribonucleotide series; and wherein the solid line represents a covalent phosphodiester bond. These compounds may be prepared from messenger RNA (mRNA) containing the genetic information necessary for cellular production of desired products such as polypeptides. After appropriate modification, they may be combined with DNA from a suitable cloning vehicle such as a plasmid and the resulting combined DNA used to transform bacterial cells. The transformed bacterial cells may then be grown and harvested; and the desired product or products recovered.
Inventors
👤 Gary V. Paddock
Bibliographic Details
Application Number—
JurisdictionUS
Data Sourcegoogle_patents
Last Synchronized2026-10-24 10:25
CPC Classifications
C; C07; C07H; C07H21/00; C12; C12N; C12N15/00
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
96 words
A compound having the general formula: ##STR10## wherein (dN) a and (dN) c represent series of deoxyribonucleotides and (rN) b represents a series of ribonucleotides; wherein a, b, and c are the numbers of nucleotides in the series; with the proviso that b is ≧1, a is ≧35, and c is ≧10, wherein the series of deoxyribonucleotides (dN) a includes a series of deoxyribonucleotides which is substantially complementary to the series of deoxyribonucleotides (dN) c and the dashed line represents a noncovalent bonding between complementary deoxyribonucleotide series; and wherein the solid lines represent covalent phosphodiester bonds.
Claim 2
Dependent Claim
96 words
A compound having the general formula: ##STR10## wherein (dN) a and (dN) c represent series of deoxyribonucleotides and (rN) b represents a series of ribonucleotides; wherein a, b, and c are the numbers of nucleotides in the series; with the proviso that b is ≧1, a is ≧35, and c is ≧10, wherein the series of deoxyribonucleotides (dN) a includes a series of deoxyribonucleotides which is substantially complementary to the series of deoxyribonucleotides (dN) c and the dashed line represents a noncovalent bonding between complementary deoxyribonucleotide series; and wherein the solid lines represent covalent phosphodiester bonds.
Claim 3
Dependent Claim
23 words
A compound in accordance with claim 1 wherein the deoxyribonucleotide series (dN) a contains information necessary for cellular production of a desired product.
Claim 4
Dependent Claim
29 words
A compound in accordance with claim 2 wherein the series (dN) a contains the information necessary for cellular production of a polypeptide or a compound containing a polypeptide portion.
Claim 5
Dependent Claim
42 words
A compound in accordance with claim 3 wherein the polypeptide or compound containing a polypeptide includes proinsulin, the polypeptide A chain of insulin, the polypeptide B chain of insulin, a growth hormone, an enzyme, an antibody, or the polypeptide portion of interferon.